Lower homocysteine levels reduces coronary restenosis rates

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1317, 2001-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sirolimus-eluting stent reduces restenosis, coronary events

By  

Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Folic acid dose-dependently reduces homocysteine levels

By  

Inpharma, Vol. 1, Iss. 1365, 2002-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

A short course of sirolimus [rapamycin] substantially reduces the rate of restenosis after bare-metal coronary stent implantation

By  

Inpharma, Vol. 1, Iss. 1537, 2006-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Coronary Brachytherapy and Restenosis

By  

Heart Drug, Vol. 1, Iss. 1, 2001-03 ,pp. : 56-65

Karger

Access to resources Recommend Favorite

Pravastatin reduces coronary events through changes in lipid levels

By  

Inpharma, Vol. 1, Iss. 1340, 2002-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite